12th Glasgow Congress on HIV Therapy, 2-6 November 2014, Glasgow
1 December 2014. Related: Conference reports.
HIV 12 Glasgow 2014
Savings to the NHS predicted from switching to generic antiretrovirals
1 December 2014. Related: Conference reports, Antiretrovirals, Treatment access.
Lower dose efavirenz effective in two studies
1 December 2014. Related: Conference reports, Antiretrovirals.
Should tenofovir dose be 200 – 250 mg when used with protease inhibitors?
1 December 2014. Related: Conference reports, Antiretrovirals.
3TC inferior to FTC in Dutch cohort but interchangeable in other studies
1 December 2014. Related: Conference reports, Antiretrovirals.
Suicide not associated with efavirenz use in the D:A:D cohort study
1 December 2014. Related: Conference reports, Antiretrovirals, Side effects.
Gender differences in use of cardiovascular disease-related interventions: D:A:D study
1 December 2014. Related: Conference reports, Treatment strategies, Women's health, Side effects.
Efavirenz decreases exposure to hormonal contraceptive implant
1 December 2014. Related: Conference reports, Antiretrovirals, Side effects.
Increased risk of ART-related hepatotoxicity in HIV positive pregnant women
1 December 2014. Related: Conference reports, Antiretrovirals, Pregnancy, Side effects.
Darunavir pharmacokinetics in pregnancy and postpartum
1 December 2014. Related: Conference reports, Antiretrovirals, Pregnancy.